See more : Applied DNA Sciences, Inc. (APDN) Income Statement Analysis – Financial Results
Complete financial analysis of Dhampur Bio Organics Limited (DBOL.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dhampur Bio Organics Limited, a leading company in the Agricultural Farm Products industry within the Consumer Defensive sector.
- International Seaways, Inc. (INSW) Income Statement Analysis – Financial Results
- Red Rock Resources plc (RRR.L) Income Statement Analysis – Financial Results
- Gores Holdings VIII, Inc. (GIIX) Income Statement Analysis – Financial Results
- SIGNA Sports United N.V. (SSUNF) Income Statement Analysis – Financial Results
- Perception Capital Corp. II (PCCTU) Income Statement Analysis – Financial Results
Dhampur Bio Organics Limited (DBOL.NS)
About Dhampur Bio Organics Limited
Dhampur Bio Organics Limited, an integrated sugarcane processing company, engages in the manufacture and sale of refined and raw sugar, biofuels, biomass based renewable power, and other related products in India. It also offers alcoholic beverage with 25% and 36% alcohol content; and ENA, a food-grade alcohol, as well as bagasse and organic fertilizer. The company was incorporated in 2020 and is based in New Delhi, India.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 18.39B | 24.08B | 15.27B | 0.00 |
| Cost of Revenue | 14.75B | 18.36B | 11.89B | 0.00 |
| Gross Profit | 3.65B | 5.71B | 3.38B | 0.00 |
| Gross Profit Ratio | 19.82% | 23.74% | 22.13% | 0.00% |
| Research & Development | 0.00 | 49.80M | 38.10M | 0.00 |
| General & Administrative | 205.50M | 104.20M | 68.40M | 0.00 |
| Selling & Marketing | 436.90M | 840.40M | 199.50M | 0.00 |
| SG&A | 642.40M | 944.60M | 267.90M | 77.64K |
| Other Expenses | 3.00B | 248.30M | 50.50M | -22.36K |
| Operating Expenses | 3.65B | 4.21B | 1.82B | 100.00K |
| Cost & Expenses | 17.58B | 22.57B | 13.71B | 100.00K |
| Interest Income | 23.10M | 4.80M | 5.20M | 0.00 |
| Interest Expense | 453.30M | 408.40M | 298.60M | 0.00 |
| Depreciation & Amortization | 494.80M | 405.30M | 312.90M | 240.00K |
| EBITDA | 1.59B | 2.16B | 1.90B | -100.00K |
| EBITDA Ratio | 8.62% | 8.98% | 12.60% | 0.00% |
| Operating Income | 924.40M | 1.76B | 1.61B | -100.00K |
| Operating Income Ratio | 5.03% | 7.29% | 10.55% | 0.00% |
| Total Other Income/Expenses | -269.50M | -412.50M | -305.10M | 0.00 |
| Income Before Tax | 654.90M | 1.35B | 1.29B | -100.00K |
| Income Before Tax Ratio | 3.56% | 5.60% | 8.45% | 0.00% |
| Income Tax Expense | 190.00M | 236.70M | 270.80M | -240.00K |
| Net Income | 464.90M | 1.11B | 1.02B | -100.00K |
| Net Income Ratio | 2.53% | 4.61% | 6.70% | 0.00% |
| EPS | 7.00 | 16.74 | 15.41 | -23.25 |
| EPS Diluted | 7.00 | 16.74 | 15.41 | -23.25 |
| Weighted Avg Shares Out | 66.41M | 66.39M | 66.39M | 4.30K |
| Weighted Avg Shares Out (Dil) | 66.39M | 66.39M | 66.39M | 4.30K |
Source: https://incomestatements.info
Category: Stock Reports